Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial

Clinical trial NCT00370422 · UNKNOWN

Trial details

NCT number: NCT00370422
Sponsor: Shahid Beheshti University of Medical Sciences
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2005-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.